BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8883787)

  • 1. Genetic susceptibility to Marek's disease virus of local chickens in Taiwan.
    Lin JA; Lee TS
    Avian Dis; 1996; 40(3):576-81. PubMed ID: 8883787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection of specific-pathogen-free chickens with Marek's disease virus (MDV) and chicken infectious anemia virus: effect of MDV pathotype.
    Miles AM; Reddy SM; Morgan RW
    Avian Dis; 2001; 45(1):9-18. PubMed ID: 11332504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First isolation and characterization of very virulent Marek's disease virus in Taiwan.
    Lin JA; Chen CP
    J Vet Med Sci; 1996 Oct; 58(10):1011-5. PubMed ID: 8916003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
    Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge.
    Islam AF; Wong CW; Walkden-Brown SW; Colditz IG; Arzey KE; Groves PJ
    Avian Pathol; 2002 Oct; 31(5):449-61. PubMed ID: 12427339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge.
    Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
    Aust Vet J; 2007 Sep; 85(9):348-55. PubMed ID: 17760936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of maternal immunity against development of Marek's disease and protective ability of vaccine.
    Yoshida I; Yuasa N; Horiuchi T; Tsubahara H
    Natl Inst Anim Health Q (Tokyo); 1975; 15(1):1-7. PubMed ID: 804667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased virulence of Marek's disease virus field isolates.
    Witter RL
    Avian Dis; 1997; 41(1):149-63. PubMed ID: 9087332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological and immunohistochemical study of chickens with co-infection of Marek's disease virus and chicken anaemia virus.
    Haridy M; Goryo M; Sasaki J; Okada K
    Avian Pathol; 2009 Dec; 38(6):469-83. PubMed ID: 19937536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity for chicks of line cells from lymphoma of Marek's disease.
    Doi K; Kojima A; Akiyama Y; Kato S
    Natl Inst Anim Health Q (Tokyo); 1976; 16(1):16-24. PubMed ID: 177892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
    Islam T; Walkden Brown SW; Renz KG; Fakhrul Islam AF; Ralapanawe S
    Avian Pathol; 2013 Dec; 42(6):516-26. PubMed ID: 24098951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development.
    Sharma JM
    Avian Dis; 1987; 31(3):570-6. PubMed ID: 2823773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of embryonic chicken lymphocytes to in ovo exposure to lymphotropic viruses.
    St Hill CA; Sharma JM
    Am J Vet Res; 1999 Aug; 60(8):937-41. PubMed ID: 10451200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.